Karyopharm Therapeutics Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Karyopharm Therapeutics Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2024.
  • Karyopharm Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 125M shares, a 9.41% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 125M +10.8M +9.41% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 125M +10.3M +9% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 116M +2.49M +2.18% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 115M +1.7M +1.5% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 115M +33.5M +41.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 114M +34.5M +43.3% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 114M +34.6M +43.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 113M +37.5M +49.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 81M +5.53M +7.32% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 79.8M +4.46M +5.93% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 79.4M +4.36M +5.81% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 75.7M +1.82M +2.47% Dec 31, 2021 10-K 2023-02-17
Q3 2021 75.5M +1.97M +2.69% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 75.3M +1.97M +2.68% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 75.1M +1.97M +2.69% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 73.9M +8.55M +13.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 73.5M +10.8M +17.3% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 73.4M +12.4M +20.3% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 73.1M +12.2M +20.1% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 65.4M +4.54M +7.47% Dec 31, 2019 10-K 2021-02-24
Q3 2019 62.7M +2.04M +3.36% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 61M +464K +0.77% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 60.9M +11.2M +22.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 60.8M +11.3M +22.8% Dec 31, 2018 10-K 2020-02-26
Q3 2018 60.7M +13.5M +28.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 60.5M +13.4M +28.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 49.7M +7.77M +18.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 49.5M +7.65M +18.3% Dec 31, 2017 10-K 2019-02-28
Q3 2017 47.2M +7.43M +18.7% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 47.1M +11.1M +30.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 41.9M +5.98M +16.6% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 41.9M +6.02M +16.8% Dec 31, 2016 10-K 2018-03-15
Q3 2016 39.7M +4.01M +11.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 36M +286K +0.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 35.9M +238K +0.67% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 35.9M +3.17M +9.68% Dec 31, 2015 10-K 2017-03-16
Q3 2015 35.7M +3.1M +9.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 35.7M +5.98M +20.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 35.7M +6.07M +20.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 32.7M +3.11M +10.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 32.6M +30M +1159% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 29.7M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 29.6M Mar 31, 2014 10-Q 2014-05-08
Q4 2013 29.6M +27.5M +1293% Dec 31, 2013 10-K 2015-03-13
Q3 2013 2.59M Sep 30, 2013 10-Q/A 2013-12-23
Q4 2012 2.12M Dec 31, 2012 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.